Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
The Laryngoscope|December 27, 2018
Over-the-Counter Tinnitus "Cures": Marketers' Promises Do Not Ring TrueVarun Vendra, Yona Vaisbuch, Albert C Mudry, et al.American Journal of Otolaryngology|May 29, 2026
Cohort study of opioid utilization in post-tonsillectomy pediatric patientsSainiteesh Maddineni, Varun Vendra, Hareem Khan, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 25, 2019
Application-Based Translaryngeal Ultrasound for the Assessment of Vocal Fold Mobility in ChildrenZahra Sayyid, Varun Vendra, Kara D Meister, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|January 5, 2021
The Future of Telemedicine: Revolutionizing Health Care or Flash in the Pan?Steven D Losorelli, Varun Vendra, Douglas M Hildrew, et al.OTO Open|July 2, 2021
Research Equity in Otolaryngology-Head and Neck SurgeryRolvix Harlan Patterson, Mary Jue Xu, Samuel Okerosi, et al.Microsurgery|December 22, 2021
Cervical paraspinal skeletal muscle index outperforms frailty indices to predict postoperative adverse events in operable head and neck cancer with microvascular reconstructionMarco A Mascarella, Lauren Gardiner, Terral Patel, et al.Journal of Geriatric Oncology|September 13, 2024
Predicting short-term treatment toxicity in head and neck cancer through a systematic review and meta-analysisMarco A Mascarella, Varun Vendra, Khalil Sultanem, et al.Head & Neck|February 14, 2024
Sarcopenia predicts short-term treatment-related toxicity in patients undergoing curative-intent therapy for head and neck cancer: A systematic review and meta-analysisMarco A Mascarella, Jannatul Ferdus, Varun Vendra, et al.Head & Neck|January 12, 2022
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A Mascarella, Terral Patel, Varun Vendra, et al.Oral Oncology|March 29, 2026
Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk indexMarco A Mascarella, Alex Mlynarek, Keith Richardson, et al.Pageof 2